Dave's Hot Chicken, a fast-growing LA-based chain, sells 75% stake to Roark Capital for nearly $1 billion, aiming for rapid domestic and global expansion.
Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.
Dave's Hot Chicken, a fast-growing LA-based chain, sells 75% stake to Roark Capital for nearly $1 billion, aiming for rapid domestic and global expansion.
Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.